REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Celltrion Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Celltrion Asia Pacific Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: research and experimental development on medical science

Headquarters
1 Paya Lebar Link, #04-01 Paya Lebar Quarter, Singapore
Singapore; Singapore; Postal Code: 408533

Contact Details: Purchase the Celltrion Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Celltrion Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Celltrion Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
August 12, 2020
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Celltrion Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
63.88%▲
Total operating revenue
63.88%▲
Net Profit (Loss) for the Period
-12.66%▼
Total assets
-1.48%▼
Total equity
-0.73%▼
Net Profit Margin
0.88%▲
Return on Equity (ROE)
-0.09%▼

Similar companies

Merck Sharp & Dohme Asia Pacific Services Pte Ltd
 
Sanofi-Aventis Singapore Pte. Ltd.
Lvmh Fragrances And Cosmetics (Singapore) Pte Ltd
 
Zuellig Pharma Pte. Ltd.
L'Oreal Singapore Pte. Ltd.
 
Johnson & Johnson Pte. Ltd.
Kalbe International Pte. Ltd.
 
Be Vaccines Pte. Ltd.
Procter & Gamble (Singapore) Pte Ltd
 
Astellas Pharma Singapore Pte. Ltd.
Eu Yan Sang (Singapore) Private Limited.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo